Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Hodgkin Lymphoma
Regimen:
GVD (gemcitabine + pegylated liposomal doxorubicin + vinorelbine tartrate)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Hodgkin Lymphoma...Relapsed/Refractory Disease...Second-Line and Subsequent Therapy...GVD (gemcitabine, vinorelbine, liposomal doxorubicin)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login